Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from China Longevity Group Co. Ltd. ( (HK:1863) ) is now available.
China Longevity Group Company Limited has issued a clarification related to its previously distributed proxy form and circular for the annual general meeting scheduled for 12 June 2026. The company confirms that, despite these corrections, the existing proxy forms already lodged by shareholders remain valid and no revised forms will be issued.
The clarification specifies that proxy forms must be lodged with the Hong Kong branch share registrar no later than 10:30 a.m. on 10 June 2026 and that share transfer documents must be lodged by 4:30 p.m. on 5 June 2026 for shareholders to be eligible to attend and vote. The company also states that its board does not recommend the payment of a final dividend for the year ended 31 December 2025, signalling no distribution to shareholders for that period.
More about China Longevity Group Co. Ltd.
China Longevity Group Company Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded under stock code 1863. The board comprises three executive directors and three independent non-executive directors, reflecting a conventional governance structure for a mid-sized Hong Kong-listed issuer, though the announcement provides no detail on its operating industry or core products.
For detailed information about 1863 stock, go to TipRanks’ Stock Analysis page.